Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Net Income Growth (1y) (2010 - 2026)

Analysis

Astrazeneca (AZN) Net Income Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn -
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn 16.52%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn -18.81%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - -
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.81%
Mar 31, 2026 22.25%
Dec 31, 2025 669.87%
Sep 30, 2025 77.82%
Jun 30, 2025 32.80%
Mar 31, 2025 13.54%
Dec 31, 2024 -73.84%
Sep 30, 2024 15.42%
Jun 30, 2024 21.65%
Mar 31, 2024 25.74%
Dec 31, 2023 970.64%
Sep 30, 2023 853.47%
Jun 30, 2023 1,658.21%
Mar 31, 2023 278.83%
Dec 31, 2022 170.63%
Sep 30, 2022 108.59%
Jun 30, 2022 -86.30%
Mar 31, 2022 -56.59%
Dec 31, 2021 -169.68%
Sep 30, 2021 -322.84%